Sacituzumab Govitecan (SG): clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Sacituzumab Govitecan (SG)

• A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
  NCT06827613 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study
  NCT07251868 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Saci Nivo Rela for TNBC
  NCT06963905 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Sacituzumab Govitecan in Metastatic Colorectal Cancer
  NCT06243393 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
  NCT06801834 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 220 locations
• Trop-2 Targeted PET Probes in Advanced TNBC
  NCT07046455 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Sacituzumab Govitecan (SG)?

6 recruiting trials across 11 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.